IRD Stock Price
Opus Genetics, Inc.
IRD stock price is $4.10 (-3.30% on the day), giving Opus Genetics, Inc. a market cap of $341.10M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
IRD Stock Overview
- Price
- $4.10
- Previous close
- $4.24
- Open
- $4.39
- Market cap
- $341.10M
- P/E ratio
- -6.9
- 52-week range
- $1.70 - $7.07
- 1-year price target
- $12.17
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 45
About Opus Genetics, Inc.
Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRD | $4.10 | -3.3% | 1.20M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |